Compare Moderna, Inc. (MRNA) vs Reddit Inc (RDDT) Price & Performance

Moderna (MRNA) trades at $63.70, up 6.5% recently, with a bullish technical signal and strong moving average support. Despite negative net income margins, the company beat Q2 2026 EPS estimates and secured FDA approval for its mRNA flu vaccine, mFLUSIVA, signaling diversification beyond COVID-19. Revenue has declined from pandemic peaks but is projected to stabilize around $2.2B in 2026.

The outlook is mixed: near-term catalysts from new vaccine approvals and pipeline progress offer upside, but persistent losses and high valuation multiples pose risks. Analyst consensus is cautious with a hold-heavy rating, reflecting uncertainty over profitability timelines amid ongoing R&D investments.

Reddit (RDDT) trades at $153.46, down 3.3% in the past 24 hours amid bearish technical signals. The company demonstrates strong fundamentals with 61% YoY revenue growth in Q2 2026 and consistent earnings beats, though recent CEO share sales and search traffic concerns have pressured the stock. Technical indicators show resistance at $160 with support at $154, while fundamentals reveal robust profitability with 91.44% gross margins and 31.35% net income margins.

Despite near-term volatility, Reddit's growth trajectory and AI integration opportunities support long-term upside potential. The consensus price target of $220.25 implies 43% upside, though risks include user growth sustainability and competitive pressures. With no sell ratings from 28 covering analysts and strong institutional interest, the stock presents a compelling growth opportunity for patient investors.